These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Exon 11 deletion in the myocyte enhancer factor (MEF)2A and early onset coronary artery disease gene in a Sicilian family. Maiolino G; Colonna S; Zanchetta M; Pedon L; Seccia TM; Cesari M; Vigili de Kreutzenberg S; Avogaro A; Rossi GP Eur J Cardiovasc Prev Rehabil; 2011 Aug; 18(4):557-60. PubMed ID: 21450604 [TBL] [Abstract][Full Text] [Related]
11. IRF2BP2 Reduces Macrophage Inflammation and Susceptibility to Atherosclerosis. Chen HH; Keyhanian K; Zhou X; Vilmundarson RO; Almontashiri NA; Cruz SA; Pandey NR; Lerma Yap N; Ho T; Stewart CA; Huang H; Hari A; Geoffrion M; McPherson R; Rayner KJ; Stewart AF Circ Res; 2015 Sep; 117(8):671-83. PubMed ID: 26195219 [TBL] [Abstract][Full Text] [Related]
12. Myocyte enhancer factor-2 transcription factors in neuronal differentiation and survival. Heidenreich KA; Linseman DA Mol Neurobiol; 2004 Apr; 29(2):155-66. PubMed ID: 15126683 [TBL] [Abstract][Full Text] [Related]
13. A study of the role of the Myocyte-specific Enhancer Factor-2A gene in coronary artery disease. Elhawari S; Al-Boudari O; Muiya P; Khalak H; Andres E; Al-Shahid M; Al-Dosari M; Meyer BF; Al-Mohanna F; Dzimiri N Atherosclerosis; 2010 Mar; 209(1):152-4. PubMed ID: 19782985 [TBL] [Abstract][Full Text] [Related]
14. MEF2A sequence variants and coronary artery disease: a change of heart? Altshuler D; Hirschhorn JN J Clin Invest; 2005 Apr; 115(4):831-3. PubMed ID: 15841171 [TBL] [Abstract][Full Text] [Related]
15. Myocardin is a direct transcriptional target of Mef2, Tead and Foxo proteins during cardiovascular development. Creemers EE; Sutherland LB; McAnally J; Richardson JA; Olson EN Development; 2006 Nov; 133(21):4245-56. PubMed ID: 17021041 [TBL] [Abstract][Full Text] [Related]
16. Myocyte enhancer factor 2 and chorion factor 2 collaborate in activation of the myogenic program in Drosophila. Tanaka KK; Bryantsev AL; Cripps RM Mol Cell Biol; 2008 Mar; 28(5):1616-29. PubMed ID: 18160709 [TBL] [Abstract][Full Text] [Related]
17. Oogenic function of the myogenic factor D-MEF2: negative regulation of the decapentaplegic receptor gene thick veins. Mantrova EY; Schulz RA; Hsu T Proc Natl Acad Sci U S A; 1999 Oct; 96(21):11889-94. PubMed ID: 10518546 [TBL] [Abstract][Full Text] [Related]
18. Relationship of the CAG repeat polymorphism of the MEF2A gene and coronary artery disease in a Chinese population. Han Y; Yang Y; Zhang X; Yan C; Xi S; Kang J Clin Chem Lab Med; 2007; 45(8):987-92. PubMed ID: 17579569 [TBL] [Abstract][Full Text] [Related]